1. Home
  2. KMPR vs ANIP Comparison

KMPR vs ANIP Comparison

Compare KMPR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

HOLD

Current Price

$23.97

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$78.86

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMPR
ANIP
Founded
1990
2001
Country
United States
United States
Employees
7400
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
KMPR
ANIP
Price
$23.97
$78.86
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$47.67
$110.00
AVG Volume (30 Days)
1.1M
346.2K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
N/A
$21.01
Revenue Next Year
$4.35
$17.59
P/E Ratio
$14.38
$58.77
Revenue Growth
N/A
2.47
52 Week Low
$22.69
$59.89
52 Week High
$65.32
$99.50

Technical Indicators

Market Signals
Indicator
KMPR
ANIP
Relative Strength Index (RSI) 29.50 48.32
Support Level N/A $76.73
Resistance Level $32.01 $83.61
Average True Range (ATR) 1.23 2.48
MACD -0.53 -0.61
Stochastic Oscillator 15.80 50.25

Price Performance

Historical Comparison
KMPR
ANIP

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: